172 related articles for article (PubMed ID: 15700837)
1. Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence.
Miyagami M; Katayama Y
Brain Tumor Pathol; 2004; 21(2):75-82. PubMed ID: 15700837
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
4. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
[TBL] [Abstract][Full Text] [Related]
5. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Marti HH; Plate KH
Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
[TBL] [Abstract][Full Text] [Related]
9. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.
Lonser RR; Butman JA; Huntoon K; Asthagiri AR; Wu T; Bakhtian KD; Chew EY; Zhuang Z; Linehan WM; Oldfield EH
J Neurosurg; 2014 May; 120(5):1055-62. PubMed ID: 24579662
[TBL] [Abstract][Full Text] [Related]
10. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
11. A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease.
Padhi S; Sarangi R; Challa S; Bussary P; Panigrahi MK; Purohit AK
J Clin Neurosci; 2011 Jul; 18(7):939-44. PubMed ID: 21570297
[TBL] [Abstract][Full Text] [Related]
12. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
Merrill MJ; Edwards NA; Lonser RR
J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
14. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
[TBL] [Abstract][Full Text] [Related]
15. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
16. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
17. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
18. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
19. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease.
Mehta GU; Asthagiri AR; Bakhtian KD; Auh S; Oldfield EH; Lonser RR
J Neurosurg Spine; 2010 Mar; 12(3):233-42. PubMed ID: 20192620
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].
Sankaredja J; Brac B; Thines L; Baroncini M; Zairi F; Cardot-Bauters C; Lejeune JP
Rev Neurol (Paris); 2014 Apr; 170(4):288-96. PubMed ID: 24680832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
